Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
1.020
+0.020 (2.04%)
Jan 22, 2026, 9:30 AM EST - Market open
Company Description
Alps Group Inc, a biotechnology company, provides research and development, medical services, and wellness solutions for advanced therapies. The company is based in Kuala Lumpur, Malaysia.
Contact Details
Address: Icon Tower (East), Unit E-18-01 & E-18-02, Level 18 Kuala Lumpur, 50400 Malaysia | |
| Phone | 60 3 2163 1113 |
| Website | alps-holdings.com |
Stock Details
| Ticker Symbol | ALPS |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 2025774 |
| CUSIP Number | G0231P108 |
| ISIN Number | KYG0231P1081 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Craig William Perry | Chairman and Chief Executive Officer |
| Darren Moulds | Chief Financial Officer |
| Michael William McCoy | Chief Operating Officer |
| William Wicker | Chief Investment Officer |
| Reagan Brown | Chief Administrative Officer |
| Chrystie Holmstrom | Chief Legal Officer and Corporate Secretary |
| Chris Nilan | Senior Managing Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 21, 2026 | 424B3 | Prospectus |
| Jan 20, 2026 | EFFECT | Notice of Effectiveness |
| Jan 8, 2026 | 6-K | Report of foreign issuer |
| Jan 7, 2026 | F-1 | Registration statement for certain foreign private issuers |
| Nov 12, 2025 | SCHEDULE 13D | Filing |
| Nov 3, 2025 | SCHEDULE 13G | Filing |
| Nov 3, 2025 | SCHEDULE 13G | Filing |
| Oct 31, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Oct 31, 2025 | 6-K/A | Filing |
| Oct 30, 2025 | CERT | Certification by an exchange approving securities for listing |